These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer's disease: Mechanisms and possible therapeutic interventions. Maitra S; Vincent B Life Sci; 2022 Nov; 308():120986. PubMed ID: 36152679 [TBL] [Abstract][Full Text] [Related]
27. CDK5 as a therapeutic tool for the treatment of Alzheimer's disease: A review. Garemilla S; Kumari R; Kumar R Eur J Pharmacol; 2024 Sep; 978():176760. PubMed ID: 38901526 [TBL] [Abstract][Full Text] [Related]
28. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. Imahori K; Uchida T J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387 [TBL] [Abstract][Full Text] [Related]
29. Olfactory Deprivation Hastens Alzheimer-Like Pathologies in a Human Tau-Overexpressed Mouse Model via Activation of cdk5. Li K; Liu FF; He CX; Huang HZ; Xie AJ; Hu F; Liu D; Wang JZ; Zhu LQ Mol Neurobiol; 2016 Jan; 53(1):391-401. PubMed ID: 25465240 [TBL] [Abstract][Full Text] [Related]
30. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models. Shi C; Viccaro K; Lee HG; Shah K J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684 [TBL] [Abstract][Full Text] [Related]
31. [Roles of cyclin-dependent kinase 5 in central nervous system development and neurodegenerative diseases]. Chen J; Wang ZF Sheng Li Xue Bao; 2010 Aug; 62(4):295-308. PubMed ID: 20717630 [TBL] [Abstract][Full Text] [Related]
32. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. Sun KH; Chang KH; Clawson S; Ghosh S; Mirzaei H; Regnier F; Shah K J Neurochem; 2011 Sep; 118(5):902-14. PubMed ID: 21668448 [TBL] [Abstract][Full Text] [Related]
36. Cdk5 as a drug target for the treatment of Alzheimer's disease. Lau LF; Seymour PA; Sanner MA; Schachter JB J Mol Neurosci; 2002 Dec; 19(3):267-73. PubMed ID: 12540052 [TBL] [Abstract][Full Text] [Related]
37. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome. Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971 [TBL] [Abstract][Full Text] [Related]
38. Cdk5 activity in the brain - multiple paths of regulation. Shah K; Lahiri DK J Cell Sci; 2014 Jun; 127(Pt 11):2391-400. PubMed ID: 24879856 [TBL] [Abstract][Full Text] [Related]
39. Role of protein kinases in neurodegenerative disease: cyclin-dependent kinases in Alzheimer's disease. Monaco EA; Vallano ML Front Biosci; 2005 Jan; 10():143-59. PubMed ID: 15574357 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles. Qin X; Wang Y; Paudel HK Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]